🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "targeted measures to address household expense issues" in next month's financial statement.

Speaking to media outlets, she emphasized that reducing inflation is a shared responsibility of both the government and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Potential Energy Cost Measures

Reports indicate the government could intervene to lower utility costs, for instance by cutting the present 5% rate of VAT charged on energy supplies.

Another approach is to lower some of the government charges currently included in bills.

Fiscal Constraints and Expert Expectations

The government will receive the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for these measures.

The consensus from most economists is that Reeves will have to declare tax increases or budget cuts in order to fulfill her voluntary debt limits.

Previously on the same day, estimates suggested there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the lower end of projections.

"It is a shared task between the Bank of England and the administration to bear down further on some of the sources of inflation," the Chancellor stated to the BBC in Washington, at the annual meetings of the IMF and World Bank.

Tax Commitments and Global Issues

While a great deal of the attention has been on likely tax rises, the Treasury chief said the latest information from the OBR had not changed her vow to campaign commitments not to increase tax levels on earnings tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with growing international and trade issues for the fiscal revenue measures, likely to be directed on those "wealthiest."

Global Trade Disputes

Commenting on concerns about the UK's trade ties with the Asian nation she said: "Our security interests invariably are paramount."

Recent announcement by China to tighten export controls on rare earths and other materials that are key for advanced tech manufacturing led US President the US President to propose an further 100% tariff on goods from the Asian country, raising the prospect of an full-scale trade war between the two global powers.

The American finance chief called China's action "commercial pressure" and "a international production power grab."

Questioned on considering the American proposal to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and urged the Chinese government "not to put up barriers and restrict access."

She said the decision was "damaging for the international commerce and generates additional headwinds."

"It is my opinion there are sectors where we need to address Chinese policies, but there are also valuable chances to export to China's economy, including banking sector and other sectors of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also confirmed she was collaborating with international partners "regarding our own critical minerals plan, so that we are reduced dependence."

Health Service Drug Costs and Funding

The Chancellor also admitted that the cost the NHS spends on drugs could go up as a consequence of current talks with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

A number of the biggest global drug companies have said in recent statements that they are either pausing or canceling operations in the UK, with some blaming the low prices they are obtaining.

Recently, the Science Minister said the price the health service spends on medicines would need to rise to stop businesses and drug research funding departing from the United Kingdom.

Reeves told media: "It has been observed because of the cost structure, that drug testing, recent pharmaceuticals have not been provided in the UK in the manner that they are in other European countries."

"Our aim is to make sure that individuals receiving treatment from the NHS are able to access the best essential drugs in the globe. And so we are examining these issues, and... aiming to secure more investment into Britain."